Methylphenidylacetate hydrochloride
Methylphenidylacetate hydrochloride Brand names, Methylphenidylacetate hydrochloride Analogs
- 4311/B Ciba
- Calocain
- Centedein
- Centedrin
- Centedrine
- Centredin
- Concerta
- Focalin
- Focalin XR
- Methylphen
- Meridil
- Metadate
- Metadate CD
- Metadate ER
- Methyl phenidyl acetate
- Methylin
- Methylin ER
- Methylofenidan
- Methylphenidan
- Methylphenidate HCl
- Methylphenidate hydrochloride
- Methylphenidatum [Inn-Latin]
- Methylphenidylacetate hydrochloride
- Methypatch
- Metilfenidat hydrochloride
- Metilfenidato [Inn-Spanish]
- Metilfenidato [Italian]
- Phenidylate
- Plimasine
- PMS-Methylphenidate
- Riphenidate
- Ritalin
- Ritalin hydrochloride
- Ritalin LA
- Ritalin SR
- Ritalin-SR
- Ritaline
- Ritcher Works
Methylphenidylacetate hydrochloride Brand Names Mixture
- No information avaliable
Methylphenidylacetate hydrochloride Chemical_Formula
C14H19NO2
Methylphenidylacetate hydrochloride RX_link
http://www.rxlist.com/cgi/generic/methphen.htm
Methylphenidylacetate hydrochloride fda sheet
Methylphenidylacetate hydrochloride msds (material safety sheet)
Methylphenidylacetate hydrochloride Synthesis Reference
M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)
Methylphenidylacetate hydrochloride Molecular Weight
233.306 g/mol
Methylphenidylacetate hydrochloride Melting Point
224-226oC
Methylphenidylacetate hydrochloride H2O Solubility
1255mg/L
Methylphenidylacetate hydrochloride State
Solid
Methylphenidylacetate hydrochloride LogP
3.192
Methylphenidylacetate hydrochloride Dosage Forms
Tablets; Tablets (sustained release)
Methylphenidylacetate hydrochloride Indication
For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.
Methylphenidylacetate hydrochloride Pharmacology
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.
Methylphenidylacetate hydrochloride Absorption
Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)
Methylphenidylacetate hydrochloride side effects and Toxicity
Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)
Methylphenidylacetate hydrochloride Patient Information
Methylphenidylacetate hydrochloride Organisms Affected
Humans and other mammals
